At the recent TIDES USA event, Erika Leonard (EL), Director of R&D at Vector Laboratories (pictured), presented a poster titled: “The Definitive Toolbox for Optimizing Bioconjugate Properties and Expediting Conjugate Synthesis.”
Showcasing the company’s BioDesign™ product, she outlined a modular set of validated bioconjugation reagents, linker technologies and conjugation strategies that have been designed to help researchers streamline the synthesis and improve the pharmacokinetic and pharmacodynamic properties of bioconjugate therapeutics.
“Toolkits such as this empower scientists to create more effective, stable and scalable drug candidates across a wide range of modalities.”
After the forum, Dr Kevin Robinson (KSR) got in touch to learn about this Nintendo equivalent for scientists and how it will make a difference to the development of next-generation therapies.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.
